These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18166475)

  • 1. Abnormal liver tests and fatty liver on ultrasound.
    Harrison SA
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):26-9. PubMed ID: 18166475
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerobic exercise and non-alcoholic fatty liver disease: a case report.
    Di Mauro D; Pagano F; Magaudda L; Speciale F; Speranza G; Bonaiuto M; Mallamace A; Trimarchi F
    J Sports Med Phys Fitness; 2009 Dec; 49(4):448-52. PubMed ID: 20087305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver involvement in gout].
    Hennecke A; Südhof H
    Dtsch Med Wochenschr; 1970 Jan; 95(2):59-62. PubMed ID: 5410008
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
    Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
    Reinehr T; Schmidt C; Toschke AM; Andler W
    Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogenic hepatopathy: a rare disease that can appear and resolve rapidly in parallel with glycemic control.
    Saadi T
    Isr Med Assoc J; 2012 Apr; 14(4):269-70. PubMed ID: 22675850
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The 10-minute consultation. Incidental finding -- increased liver values].
    Dancygier H
    MMW Fortschr Med; 2004 Dec; 146(50):75-6. PubMed ID: 15658526
    [No Abstract]   [Full Text] [Related]  

  • 12. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2013 Dec; 19(4):325-48. PubMed ID: 24459637
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated hepatic enzymes potentially associated with sitagliptin.
    Gross BN; Cross LB; Foard J; Wood Y
    Ann Pharmacother; 2010 Feb; 44(2):394-5. PubMed ID: 20103614
    [No Abstract]   [Full Text] [Related]  

  • 14. [Common biochemical changes in obesity related liver diseases].
    Gao CF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):433. PubMed ID: 15268812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of NASH: nutritional counseling and physical exercise].
    Yoneda M; Fujita K; Iwasaki T; Maeyama S; Terauchi Y; Nakajima A
    Nihon Rinsho; 2006 Jun; 64(6):1139-45. PubMed ID: 16768122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation.
    Akın L; Kurtoglu S; Yikilmaz A; Kendirci M; Elmalı F; Mazicioglu M
    Acta Paediatr; 2013 Mar; 102(3):e107-13. PubMed ID: 23190373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of abnormal liver-enzyme results in asymptomatic patients.
    Verslype C
    Acta Clin Belg; 2004; 59(5):285-9. PubMed ID: 15641399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on fatty liver of various etiology and stage with reference to clinical aspects and functional diagnosis].
    Weise J; Rösch D
    Acta Hepatosplenol; 1971; 18(2):104-19. PubMed ID: 4101558
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of weight control on hepatic abnormalities in obese patients with fatty liver.
    Park HS; Kim MW; Shin ES
    J Korean Med Sci; 1995 Dec; 10(6):414-21. PubMed ID: 8924225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.